medigraphic.com
ISSN 0138-7103 (Print)

2022, Number 2

<< Back Next >>

Revista del Hospital Psiquiátrico de La Habana 2022; 19 (2)

Comparative effectiveness between antidepressants and psychotherapy

Rodríguez VJL, Guevara VAM, Celso PP, Mejía PDA, Gómez SLF, Calderón MWL

Language: Spanish
References: 52
Page:
PDF size: 339.14 Kb.


ABSTRACT

This study is a systematic review and meta-analysis that seeks the comparative effectiveness of pharmacological treatment and psychotherapy in major depressive disorder. The methodology of Evidence-Based Medicine was used; robust bibliometric and statistical strategies were employed to consolidate the information of 1000 articles published from 1916 to 2022, and focused on the last five years, 2018 – 2022. There were 20 with high impact and relevant “h” index. 59% of the articles supported combined therapy, and 41% evenly considered pharmacotherapy more efficient than cognitive-behavioral psychotherapy. No study concluded that the use of antidepressants is overall more effective than psychotherapy. It is concluded that pharmacological therapy is more effective than psychotherapy, but if both are combined in different plans, the effectiveness achieved is much greater as long as cognitive behavioral therapy is used.


REFERENCES

  1. Xiang Y, Cuijpers P, Teng T, Li X, Fan L, Liu X, et al. Comparative short-termefficacy and acceptability of a combination of pharmacotherapy andpsychotherapy for depressive disorder in children and adolescents: a systematicreview and meta-analysis. BMC Psychiatry 2022;22(1).

  2. Selaskowski B, Staerk C, Braun N, Matthies S, Graf E, Colla M, et al. Multimodaltreatment efficacy differs in dependence of core symptom profiles in adultAttention-Deficit/Hyperactivity Disorder: An analysis of the randomizedcontrolled COMPAS trial. J Psychiatr Res 2022;151:225-34.

  3. Fugger G, Bartova L, Fabbri C, Fanelli G, Dold M, Swoboda MMM, et al. Thesociodemographic and clinical profile of patients with major depressive disorderreceiving SSRIs as first-line antidepressant treatment in European countries. EurArch Psychiatry Clin Neurosci 2022;272(4):715-27.

  4. Laux G. Parkinson and depression: review and outlook. J Neural Transm2022;129(5-6):601-8.

  5. Caldiroli A, Capuzzi E, Tagliabue I, Capellazzi M, Marcatili M, Mucci F, et al.Augmentative pharmacological strategies in treatment‐resistant majordepression: A comprehensive review. Int J Mol Sci 2021;22(23).

  6. Lancee J, Effting M, Kunze AE. Telephone-guided imagery rehearsal therapy fornightmares: Efficacy and mediator of change. J Sleep Res 2021;30(3).

  7. Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, et al. Newgeneration antidepressants for depression in children and adolescents: a networkmeta-analysis. Cochrane Database Syst Rev 2021;2021(5).

  8. Goossens J, Morrens M, Coppens V. The Potential Use of Peripheral BloodMononuclear Cells as Biomarkers for Treatment Response and Outcome Predictionin Psychiatry: A Systematic Review. Mol Diagn Ther 2021;25(3):283-99.

  9. Fuhr K, Meisner C, Broch A, Cyrny B, Hinkel J, Jaberg J, et al. Efficacy ofhypnotherapy compared to cognitive behavioral therapy for mild to moderatedepression - Results of a randomized controlled rater-blind clinical trial. JAffective Disord 2021;286:166-73.

  10. Maguire MJ, Marson AG, Nevitt SJ. Antidepressants for people with epilepsy anddepression. Cochrane Database Syst Rev 2021;2021(4).

  11. Malhi GS, Bell E, Mannie Z, Bassett D, Boyce P, Hopwood M, et al. Profiling rTMS:A critical response. Aust New Zealand J Psychiatry 2021;55(4):355-65.

  12. Nussbaumer-Streit B, Thaler K, Chapman A, Probst T, Winkler D, Sönnichsen A,et al. Second-generation antidepressants for treatment of seasonal affectivedisorder. Cochrane Database Syst Rev 2021;2021(3).

  13. Zhou D, Zhou X, Lin Q, Wang W, Lv Z, Chen X, et al. Nonpharmacologicalinterventions for relapse prevention in unipolar depression: A network metaanalysis.J Affective Disord 2021;282:1255-1262.

  14. Wright I, Mughal F, Bowers G, Meiser-Stedman R. Dropout from randomisedcontrolled trials of psychological treatments for depression in children and youth:a systematic review and meta-analyses. J Affective Disord 2021;281:880-890.

  15. Liu W, Li G, Wang C, Wang X, Yang L. Efficacy of Sertraline Combined withCognitive Behavioral Therapy for Adolescent Depression: A Systematic Reviewand Meta-Analysis. Comp Math Methods Med 2021;2021.

  16. Hieronymus F, Hieronymus M, Nilsson S, Eriksson E, Østergaard SD. Individualvariability in treatment response to antidepressants in major depression:comparing trial-level and patient-level analyses. Acta Psychiatr Scand2020;142(6):443-445.

  17. Abou El-Magd RM, Obuobi-Donkor G, Adu MK, Lachowski C, Duddumpudi S, LawalMA, et al. Repetitive transcranial magnetic stimulation with and withoutinternet-delivered cognitive-behavioral therapy for the treatment of resistantdepression: Protocol for patient-centered randomized controlled pilot trial. JMIRRes Prot 2020;9(10).

  18. Lee Y, Brietzke E, Cao B, Chen Y, Linnaranta O, Mansur RB, et al. Developmentand implementation of guidelines for the management of depression: Asystematic review. Bull WHO 2020;98(10):683-697H.

  19. Kan K, Feenstra TL, de Vries SO, Visser E, Schoevers RA, Jörg F. The clinicaleffectiveness of an algorithm-guided treatment program for depression inspecialized mental healthcare: A comparison with efficacy trials. J AffectiveDisord 2020;275:216-223.

  20. Pahlevan T, Ung C, Segal Z. Cost–Utility Analysis of Mindfulness-Based CognitiveTherapy Versus Antidepressant Pharmacotherapy for Prevention of DepressiveRelapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive baséesur la pleine conscience contre la pharmacothérapie antidépressive pour prévenirla rechute de la dépression en contexte canadien. Can J Psychiatry2020;65(8):568-576.

  21. Hetrick SE, Meader N, Bailey AP, Badcock PB, Moller CI, Cox GR, et al. Newgeneration antidepressants for depression in children and adolescents: a networkmeta-analysis. Cochrane Database Syst Rev 2020;2020(7).

  22. Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, et al.Comparative efficacy and acceptability of antidepressants, psychotherapies, andtheir combination for acute treatment of children and adolescents withdepressive disorder: a systematic review and network meta-analysis. LancetPsychiatry 2020;7(7):581-601.

  23. Lin A, Stolfi A, Eicher T, Neeley S. Predicting second-generation antidepressanteffectiveness in treating sadness using demographic and clinical information: Amachine learning approach. J Affective Disord 2020;272:295-304.

  24. Wu W, Zhang Y, Jiang J, Lucas MV, Fonzo GA, Rolle CE, et al. Anelectroencephalographic signature predicts antidepressant response in majordepression. Nat Biotechnol 2020;38(4):439-447.

  25. Whiston A, Bockting CLH, Semkovska M. Towards personalising treatment: Asystematic review and meta-analysis of face-to-face efficacy moderators ofcognitive-behavioral therapy and interpersonal psychotherapy for majordepressive disorder. Psychol Med 2019;49(16):2657-2668.

  26. Lopez-Gomez I, Lorenzo-Luaces L, Chaves C, Hervas G, DeRubeis RJ, Vazquez C.Predicting optimal interventions for clinical depression: Moderators of outcomesin a positive psychological intervention vs. cognitive-behavioral therapy. GenHosp Psychiatry 2019;61:104-110.

  27. Cao X-, Huang X-, Wang X. Effectiveness of Chinese herbal medicine granules andtraditional Chinese medicine-based psychotherapy for perimenopausaldepression in Chinese women: A randomized controlled trial. Menopause2019;26(10):1193-1203.

  28. D'Anci KE, Uhl S, Giradi G, Martin C. Treatments for the prevention andmanagement of suicide. Ann Intern Med 2019;171(5):334-342.

  29. Forneris CA, Nussbaumer-Streit B, Morgan LC, Greenblatt A, Van Noord MG,Gaynes BN, et al. Psychological therapies for preventing seasonal affectivedisorder. Cochrane Database Syst Rev 2019;2019(5).

  30. Machmutow K, Meister R, Jansen A, Kriston L, Watzke B, Härter MC, et al.Comparative effectiveness of continuation and maintenance treatments forpersistent depressive disorder in adults. Cochrane Database Syst Rev2019;2019(5).

  31. Goff DC. Can Adjunctive Pharmacotherapy Reduce Hospitalization inSchizophrenia?: Insights from Administrative Databases. JAMA Psychiatry2019;76(5):468-70.

  32. Gartlehner G, Nussbaumer-Streit B, Gaynes BN, Forneris CA, Morgan LC,Greenblatt A, et al. Second-generation antidepressants for preventing seasonalaffective disorder in adults. Cochrane Database Syst Rev 2019;2019(3).

  33. Nussbaumer-Streit B, Forneris CA, Morgan LC, Van Noord MG, Gaynes BN,Greenblatt A, et al. Light therapy for preventing seasonal affective disorder.Cochrane Database Syst Rev 2019;2019(3).

  34. Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, Agbor-Tabi D, Huber M, WangZ. Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic StressDisorder: A Randomized, Placebo-Controlled Pilot Study of AugmentationTherapy. J Clin Psychopharmacol 2019;39(2):153-7.

  35. Ross EL, Vijan S, Miller EM, Valenstein M, Zivin K. The cost-effectiveness ofcognitive behavioral therapy versus second-generation antidepressants for initialtreatment of major depressive disorder in the United States a decision analyticmodel. Ann Intern Med 2019;171(11):785-95.

  36. Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, et al. Sex differencesin psychoeducation for patients with depression: A comparison of frequency andefficacy of psychoeducation. Neuropsychiatr Dis Treat 2019;15:3069-78.

  37. Rosenblat JD, Carvalho AF, Li M, Lee Y, Subramanieapillai M, McIntyre RS. Oralketamine for depression: A systematic review. J Clin Psychiatry 2019;80(3).

  38. Hilbert A, Petroff D, Herpertz S, Pietrowsky R, Tuschen-Caffier B, Vocks S, et al.Meta-Analysis of the Efficacy of Psychological and Medical Treatments for Binge-Eating Disorder. J Consult Clin Psychol 2019;87(1):91-105.

  39. Ot’alora G M, Grigsby J, Poulter B, Van Derveer JW, Giron SG, Jerome L, et al.3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment ofchronic posttraumatic stress disorder: A randomized phase 2 controlled trial. JPsychopharmacol 2018;32(12):1295-1307.

  40. Maroun RA, Thackeray LA, Midgley N. Meaning and medication: A thematicanalysis of depressed adolescents' views and experiences of SSRI antidepressantsalongside psychological therapies 11 Medical and Health Sciences 1103 ClinicalSciences 11 Medical and Health Sciences 1117 Public Health and Health Services17 Psychology and Cognitive Sciences 1701 Psychology. BMC Psychiatry2018;18(1).

  41. Li J-, Zhang Y, Su W-, Liu L-, Gong H, Peng W, et al. Cognitive behavioral therapyfor treatment-resistant depression: A systematic review and meta-analysis.Psychiatry Res 2018;268:243-50.

  42. Rhee TG, Capistrant BD, Schommer JC, Hadsall RS, Uden DL. Effects of the 2009USPSTF depression screening recommendation on diagnosing and treating mentalhealth conditions in older adults: A difference-in-differences analysis. J ManagCare Spec Pharm 2018;24(8):769-76.

  43. Ross EL, Zivin K, Maixner DF. Cost-effectiveness of electroconvulsive therapy vspharmacotherapy/psychotherapy for treatment-resistant depression in theUnited States. JAMA Psychiatry 2018;75(7):713-22.

  44. Rief W, Bleichhardt G, Dannehl K, Euteneuer F, Wambach K. Comparing theefficacy of CBASP with two versions of CBT for depression in a routine carecenter: A randomized clinical trial. Psychother Psychosom 2018;87(3):164-78.

  45. Jelinek L, Hauschildt M, Hottenrott B, Kellner M, Moritz S. “Association splitting”versus cognitive remediation in obsessive-compulsive disorder: A randomizedcontrolled trial. J Anxiety Disord 2018;56:17-25.

  46. Goetter EM, Mauro CM, Qiu X, Skritskaya NA, Reynolds CF, Zisook S, et al.Treatment expectancy and working alliance in pharmacotherapy as predictors ofoutcomes in complicated grief. J Consult Clin Psychol 2018;86(4):367-371.

  47. Smith CA, Armour M, Lee MS, Wang L-, Hay PJ. Acupuncture for depression.Cochrane Database Syst Rev 2018;2018(3).

  48. Christensen MC, Loft H, McIntyre RS. Vortioxetine improves symptomatic andfunctional outcomes in major depressive disorder: A novel dual outcome measurein depressive disorders. J Affective Disord 2018;227:787-794.

  49. Bow A. Is electroconvulsive therapy any more effective than simulatedelectroconvulsive therapy in treatment-resistant depression? Psychiatr Danub2018;30:S502-S507.

  50. Liew TM, Lee CS. Comparative efficacy and acceptability of interventions formajor depression in older persons: Protocol for Bayesian network meta-analysis.BMJ Open 2018;8(1).

  51. Bonanni L, Franciotti R, Martinotti G, Vellante F, Flacco ME, Di Giannantonio M,et al. Post traumatic stress disorder heralding the onset of semanticfrontotemporal dementia. J Alzheimer's Dis 2018;63(1):203-215.

  52. Barton B, Schramm E, Voderholzer U. Short and long-term efficacy ofpsychotherapy compared to pharmacological treatment for depression. Z PsychPsychol Psychother 2018;66(1):19-29.




2020     |     www.medigraphic.com